TAMPA, Fla., May 3, 2024 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (Nasdaq: MRAI), an independent national Third-Party Administration (TPA) company transforming the $22 billion TPA market supporting self-funded employer health plans with affordable, intelligent, healthcare, will host a conference call and webcast on Friday, May 10 at 8:30 a.m. ET to answer questions about the Company's operational and financial highlights for its first quarter 2024. The Company will report its first quarter results on Thursday after the market close.
Event: | Marpai First Quarter Financial Results Conference Call |
Date: | May 10, 2024 |
Time: | 8:30 a.m. Eastern Time |
Live Call: | US: 1-646-357-8785 / Toll Free: 1-800-836-8184 |
Webcast: |
To instantly join the conference call by phone, please use the following link to easily register close to the call start time. After registering, the system will call you instantly and connect you into the conference call automatically: https://emportal.ink/3QoFTM8
Alternatively, you may dial in to the conference call by calling 1-646-357-8785 or 1-800-836-8184 and you will be connected to the call by an Operator.
You may also stream the call by Webcast by following this link: https://app.webinar.net/MVqDW74kNpl The webcast replay will be available at the same URL within 2 hours of the end of the call.
A replay of the call will be available within 2 hours of the end of the call until May 30, 2024 by calling 1-646-517-4150 or 1-888-660-6345 and entering the replay code, 31949 #.
About Marpai, Inc.
Marpai, Inc. (Nasdaq: MRAI) is a leading, national TPA company bringing value-oriented health plan services to employers that directly pay for employee health benefits. Primarily competing in the $22 billion TPA sector serving self-funded employer health plans representing over $1 trillion in annual claims. Marpai works to deliver the healthiest member population for the health plan budget. Operating nationwide, Marpai offers access to leading provider networks including Aetna and Cigna and all TPA services. For more information, visit www.ir.marpaihealth.com, the content of which is not incorporated by reference into this press release.
Last Trade: | US$1.40 |
Daily Change: | -0.05 -3.45 |
Daily Volume: | 9,646 |
Market Cap: | US$24.390M |
August 13, 2025 May 14, 2025 May 13, 2025 |
Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MOREImmix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...
CLICK TO LEARN MOREEnd of content
No more pages to load